glp-1 agonist or antagonist GIPR/GLP-1R dual therapies for diabetes and weight loss—chemistry, physiology, and clinical applications A Closer Look at the

The cost for each drug can easily exceed $1000 per month

Data from wearables and medical devices are fed directly into their apps, and this data allows them to track lifestyle changes and encourage habit formation, building toward sustainable behavior modifications that maximize the long-term success of GLP-1 programs

Pharmacology of dipeptidyl peptidase-4 inhibitors: Similarities and differences

Analyses of treatment adherence effect showed a near constant effect for adherent users (risk ratio 0.55) at one, two, and three years

For comparison, 70% of ACA Marketplace plans use at least 1 utilization management strategy with Xarelto (covered on 97% of formularies), a similarly priced oral anticoagulant with no generic formulation available

doi:10.1111/j.1463-1326.2010.01259.x 141